Psilocybin reduces symptoms in treatment resistant depression, trial results show
British medical journal November 2, 2022 G. Iacobucci 5 citations
single a Researchers investigated the effects of single doses of 25 mg, 10 mg, or 1 mg (control) psilocybin over 12 weeks in 233 patients with treatment resistant depression. They were given the treatment in specialised rooms designed to provide a non-clinical and calming atmosphere where a specially trained therapist was available to provide psychological support. The psychedelic effects of...